About six years ago, almost simultaneously, three independent groups reported the synthesis of a novel class of dendritic molecules. These molecules were equipped with a focal trigger; reaction at the trigger initiated the fragmentation of the dendrimer to its building blocks in a domino-like manner with consequent release of at least two tail-units. We termed these molecules “self-immolative dendrimers” and demonstrated their distinctive ability to achieve molecular amplification of the initial triggering signal. The unique amplification effect obtained by self-immolative dendrimers is useful in the fields of drug delivery systems and diagnostic applications. This highlight summarizes the design, function, and applications of this unique class of molecules.
No takes yet. Share an insight, caveat, or question.
Avital‐Shmilovici et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: